T
TSHA//CIK 0001806310
Taysha Gene Therapies, Inc.
Market Data
$4.55−$0.32 (−6.48%)
TSHA · Last trade
Prev Close
$4.86
Range (31d)
$4.41 – $5.09
Recent Filings
- 8-K329.2 KBTaysha Gene Therapies, Inc.Nov 4, 7:12 AM ET·0001193125-25-263543
- 10-Q16.8 MBTaysha Gene Therapies, Inc.Nov 4, 6:54 AM ET·0001193125-25-263506
- 8-K165.4 KBTaysha Gene Therapies, Inc.Oct 16, 4:10 PM ET·0001193125-25-241415
- 8-K170.6 KBTaysha Gene Therapies, Inc.Oct 9, 8:24 AM ET·0001193125-25-235212
- 8-K170.0 KBTaysha Gene Therapies, Inc.Oct 2, 8:10 AM ET·0001193125-25-227505
- 10-Q14.0 MBTaysha Gene Therapies, Inc.Aug 12, 10:48 AM ET·0000950170-25-107010
- 8-K244.6 KBTaysha Gene Therapies, Inc.Aug 12, 8:10 AM ET·0001193125-25-178504
- 8-K164.3 KBTaysha Gene Therapies, Inc.Jun 3, 7:00 AM ET·0001193125-25-133745
- 8-K1.7 MBTaysha Gene Therapies, Inc.May 29, 4:38 PM ET·0001193125-25-130709
- 8-K/A14.1 MBTaysha Gene Therapies, Inc.May 29, 6:02 AM ET·0001193125-25-129849
Insiders
10- Alam KamranCHIEF FINANCIAL OFFICER
- Astellas Pharma Inc.10% Owner
- Audentes Therapeutics, Inc.10% Owner
- Donenberg Phillip B.Director
- Long Alison SDirector
- Manning Paul B10% Owner
- Nagendran SukumarDirector, President and Head of R&D
- Nolan Sean P.Director, Chief Executive Officer
- PRASAD SUYASHCMO and Head of R&D
- Reape KathleenDirector
Tickers
Addresses
business
3000 PEGASUS PARK DRIVE SUITE 1430
DALLAS, TX, 75247
mailing
3000 PEGASUS PARK DRIVE SUITE 1430
DALLAS, TX, 75247